Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
106.28
-2.13 (-1.96%)
Feb 21, 2025, 4:00 PM EST - Market closed
Sarepta Therapeutics Analyst Ratings
Total Analysts
22
Consensus Rating
Buy
Price Target
$174.64
Upside
+64.32%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $75 | Strong Sell | Reiterates | $75 | -29.43% | Feb 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $75 | Strong Sell | Reiterates | $75 | -29.43% | Jan 30, 2025 |
| Needham | Needham | Strong Buy Reiterates $202 | Strong Buy | Reiterates | $202 | +90.06% | Jan 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $75 | Strong Sell | Reiterates | $75 | -29.43% | Jan 15, 2025 |
| Needham | Needham | Strong Buy Reiterates $202 | Strong Buy | Reiterates | $202 | +90.06% | Jan 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $75 | Strong Sell | Reiterates | $75 | -29.43% | Dec 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Maintains $80 → $75 | Strong Sell | Maintains | $80 → $75 | -29.43% | Dec 3, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $200 → $182 | Buy | Maintains | $200 → $182 | +71.25% | Nov 27, 2024 |
| Needham | Needham | Strong Buy Maintains $205 → $202 | Strong Buy | Maintains | $205 → $202 | +90.06% | Nov 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Initiates $80 | Strong Sell | Initiates | $80 | -24.73% | Nov 25, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $148 → $150 | Strong Buy | Maintains | $148 → $150 | +41.14% | Nov 7, 2024 |
| Baird | Baird | Buy Maintains $200 → $193 | Buy | Maintains | $200 → $193 | +81.60% | Nov 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold → Buy Upgrades $152 → $167 | Hold → Buy | Upgrades | $152 → $167 | +57.13% | Nov 7, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $179 → $170 | Buy | Maintains | $179 → $170 | +59.95% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $205 | Strong Buy | Reiterates | $205 | +92.89% | Nov 7, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $182 | Buy | Reiterates | $182 | +71.25% | Oct 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.